A viral adaptor protein modulating casein kinase II activity induces cytopathic effects in permissive cells

Jürg P F Nüesch1, Jean Rommelaere

  • 1Program "Infection and Cancer," Abteilung F010 and Institut National de la Santé et de la Recherche Médicale Unité 701, Deutsches Krebsforschungszentrum, D-69120 Heidelberg, Germany. jpf.nuesch@dkfz.de

Insights

The parvovirus NS1 protein causes cell damage by linking casein kinase II (CKII) to tropomyosin, altering cell structures. This NS1 adaptor function is crucial for parvovirus-induced cell death and cytoskeletal changes.

Area of Science:

  • Virology
  • Cell Biology
  • Biochemistry

Background:

  • Autonomous parvoviruses cause significant cell damage (cytopathic effects, CPE) through cytoskeletal disruption.
  • Casein kinase II (CKII) inhibition protects cells from Minute virus of mice (MVM)-induced CPE, suggesting its role in MVM toxicity.

Purpose of the Study:

  • To investigate the role of the parvoviral NS1 protein in mediating CKII-dependent cytoskeletal alterations and cell death.
  • To elucidate the mechanism by which NS1 induces CPE.

Main Methods:

  • Investigated the interaction between NS1, CKIIalpha, and tropomyosin using in vitro and in vivo assays.
  • Analyzed the effect of NS1 mutations on binding affinities and CPE induction.
  • Utilized fusion peptides to confirm the adaptor function of NS1.

Main Results:

  • The parvoviral NS1 protein directly mediates CKII-dependent cytoskeletal alterations and cell death.
  • NS1 acts as an adaptor, linking CKIIalpha to tropomyosin, altering tropomyosin phosphorylation.
  • Mutations in NS1 that disrupt binding to CKIIalpha or tropomyosin impair its ability to induce CPE.
  • Fusion peptides mimicking NS1's adaptor function induced cell death in MVM-permissive cells.

Conclusions:

  • The NS1 protein's cytotoxic adaptor function, linking CKIIalpha and tropomyosin, is essential for inducing parvovirus-mediated cell death.
  • NS1's ability to modulate tropomyosin phosphorylation via CKII is a key mechanism driving parvoviral CPE.

Related Concept Videos

cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...